Acamprosate Completed Phase 4 Trials for Alcohol Dependence / Major Depressive Disorder (MDD) / Social Anxiety Disorder (SAD) / Generalized Anxiety Disorder (GAD) Treatment

CompletedTreatment4 IdentifierTitleDrugs
NCT00330174Acamprosate in Alcoholics With Comorbid Anxiety or Depression
NCT00159107Integrative Therapy in Alcoholism
NCT00855699Alcohol Detoxification in Primary Care Treatment (ADEPT)
NCT00381043Study of Campral (Acamprosate) for Alcohol Dependence in a Family Medicine Clinic
NCT00435435Comparative Trial Of Disulfiram, Naltrexone And Acamprosate In The Treatment Of Alcohol Dependence